|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Oramed Pharmaceuticals (NASDAQ: ORMP) through any online brokerage.
The latest price target for Oramed Pharmaceuticals (NASDAQ: ORMP) was reported by Canaccord Genuity on July 29, 2021. The analyst firm set a price target for 30.00 expecting ORMP to rise to within 12 months (a possible 32.68% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $22.61 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Oramed Pharmaceuticals.
Oramed Pharmaceuticals’s $Q1 earnings are confirmed for after-market on $January 13, 2022.
There is no upcoming split for Oramed Pharmaceuticals.
Oramed Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.